SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001012975-06-000180
Filing Date
2006-04-13
Accepted
2006-04-13 16:27:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 e8444575v1.txt SC 13D/A 19786
  Complete submission text file 0001012975-06-000180.txt   21627
Mailing Address
Business Address 8725 W HIGGINS RD STE 290 CHICAGO IL 60631
ARCH VENTURE FUND V LP (Filed by) CIK: 0001117120 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078
Business Address 150 JOHN F. KENNEDY PARKWAY SUITE 100 SHORT HILLS NJ 07078 44 1382 207506
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80136 | Film No.: 06758761
SIC: 2834 Pharmaceutical Preparations